Aller au contenu principal
2025 conference-abstract

S2871 Evaluating the Efficacy and Safety of Hypovolemic Phlebotomy in Patients With Liver Surgery: A Systematic Review and Meta-Analysis

0Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Le résumé fourni par la source

Introduction: Significant blood loss is common in major liver surgery, heightening the need for transfusions and increasing postoperative risks. Hypovolemic phlebotomy (HP) has surfaced as an effective method to reduce bleeding by decreasing central venous pressure, all without the need for volume replacement. This meta-analysis examines the safety and effectiveness of HP in reducing blood loss during liver resection. Methods: From inception until March 2025, a comprehensive literature review was performed using PubMed, Cochrane Central, and ScienceDirect. Risk ratios (RR) and weighted mean differences (WMD) for both categorical and continuous outcomes were aggregated utilizing the random effects model in Review Manager software version 5.4.1. A sensitivity analysis, which excluded one study at a time, was executed to evaluate heterogeneity. The assessment of quality was conducted using the Cochrane risk of bias tool and the Newcastle-Ottawa scale. Results: This meta-analysis includes 8 studies with a total of 1,901 patients. In the HP group, blood loss is significantly lower compared to the placebo group (MD: -440.13 mL; 95% CI: [-756.20, -124.07]; P = 0.006). The HP arm also sees a notable decrease in hospital stay length (MD = -15.98 days; 95% CI: [-21.36, -10.60]; P < 0.01). Other measures, including red blood cell transfusion (RR = 0.60; 95% CI:[0.35, 1.04]; P = 0.07), major complications (RR = 1.40; 95% CI: [0.93, 2.13]; P = 0.11), and overall complications (RR = 1.15; 95% CI: [0.86, 1.53]; P = 0.35), show comparable results between both groups. Conclusion: HP greatly minimizes blood loss during liver resection surgery and shortens hospital stays for patients while avoiding an increase in transfusion requirements or complications, demonstrating its safety and efficacy. Additional research could further enhance its implementation in clinical settings.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
S2871 Evaluating the Efficacy and Safety of Hypovolemic Phlebotomy in Patients With Liver Surgery: A Systematic Review and Meta-Analysis
Date Crossref
01/10/2025
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les sujets associés

Abdominal Surgery and ComplicationsHemodynamic Monitoring and TherapyOrgan Transplantation Techniques and Outcomes

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.